Overview
- Description
The company is a spin-off from the University of Valencia developing advanced RNA treatments for genetic diseases, with a focus on myotonic dystrophy type 1.
- Website
- Country
- Spain
- Sector
- Health Biotechnology
ARTHEX BIOTECH S.L.
Anti-microRNAs designed for the treatment of diseases with unmet needs.